Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin

Journal of Autoimmunity

Volumn 15, Issue 4, 2000, Pages 395-405

  Nicoletti, Ferdinando ^a   Di Marco, Roberto ^b   Conget, Ignacio ^c   Gomis, Ramon ^c   Edwards III, Carl ^d   Papaccio, Gianpaolo ^e   Bendtzen, Klaus ^f   Sandler, Stellan ^g  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c HOSPITAL CLÍNIC   (Spain)

^d AMGEN INC   (United States)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f Rigshospitalet   (Denmark)

^g UPPSALA UNIVERSITY   (Sweden)

Author keywords

Fusidin; Immunotherapy; Interferon ; Multiple low doses; Streptozotocin induced diabetes

Indexed keywords

CONCANAVALIN A; CYTOKINE; FUSIDATE SODIUM; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 6; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEEDING; HYPERGLYCEMIA; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; STREPTOZOCIN DIABETES;

EID: 0033637617     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0448     Document Type: Article

References (60)

1. Streptozotocin-induced pancreatic insulitis: New model of diabetes mellitus
2. Mouse model of insulin depenctent diabetes: Low-dose streptozotocin induced diabetes and nonobese diabetic (NOD) mouse
3. Viral studies in streptozotocin-induced pancreatic insulitis
4. Low-dose streptozotocin-induced diabetes in mice. Electron microscopy reveals single cell insulitis before diabetes onset
5. Treatment with anti-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozotocin
6. Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody
7. L3T4 and Lyt-2+ T cells are both involved in the generation of low-dose streptozotocin-induced diabetes in mice
8. Administration of silica or monoclonal antibody to Thy-1 prevents low-dose streptozotocin induced diabetes in mice
9. Islet expression of interferon-alpha precedes diabetes in both BB rat and streptozotocin-treated mice
10. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin
11. Interleukin-1 receptor antagonist prevents low dose streptozotocin-induced diabetes in mice
12. Anti-interleukin-2 receptor antibody attenuates low-dose streptozotocin-induced diabetes in mice
13. Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-gamma
14. IFN-gamma receptor-Ig fusion proteins. Half life, immunogenicity and in vivo activity
15. Cytokines and the endocrine system. II. Roles in substrate metabolism, modulation of thyroidal and pancreatic endocrine cell functions and autoimmune endocrine diseases
16. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus
17. Nitric oxide in autoimmune disease: Cytotoxic or regulatory mediator?
18. Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats
19. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: Identification of iNOS expressing cells and relationship to cytokines expressed in the islets
20. The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic beta cells
21. Inhibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice
22. Suppression of low-dose streptozotocin-induced diabetes in mice by administration of nitric oxide synthase inhibitor
23. Aminoguanidine, an inhibitor of nitric oxide formation fails to protect against insulitis and hyperglycaemia induced by multiple low dose streptozotocin injections in mice
24. Administration of a nitric oxide synthase inhibitor does not suppress low-dose streptozotocin-induced diabetes in mice
25. S-methyl-L-thiocitrulline counteracts interleukin-1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low dose stretozotocin-induced diabetes in vivo
26. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes
27. Fusidic acid and insulin-dependent diabetes mellitus
28. Fusidic acid, an immunosuppressive drug with functions similar to cyclosporin A
29. Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock
30. Anti-tumor necrosis factor properties of non-peptide drugs in acute-phase responses
31. Improved survival and antagonistic effect of sodium fusidate on tumor necrosis factor alpha in a neonatal mouse model of endotoxin shock
32. Protection from concanavalin A (Con A)-induced T cell-dependent hepatic lesions and modulation of cytokine release in mice by sodium fusidate
33. Anti-diabetogenic effect of fusidic acid in diabetes-prone BB rats
34. Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-γ
35. Sodium fusidate and increased remission rate of insulin-dependent diabetes mellitus
36. Treatment of chronic endogenous uveitis with fusidic acid
37. Sodium fusidate in Guillian-Barre syndrome. A case report
38. Amelioration of experimental allergic neuritis by sodium fusidate (fusidin) suppression of IFN-gamma and TNF-alpha and enhancement of IL-10
39. Sodium fusidate in steroid resistant relapses of multiple sclerosis
40. Fusidic acid for Bechet's colitis: A novel approach to T-cell specific immunosuppressive therapy
41. Treatment of Chron's disease with fusidic acid: An antibiotic with immunosuppressive properties similar to cyclosporin
42. Therapieversuch mit Fucidin bei systemicher Sklerodermic
43. Sodium fusidate and the cytokine response in an experimental model of acute pancreatitis
44. Monoclonal antibodies against murine γ interferon
45. The effects of a monoclonal antibody to interferon-γ on experimental autoimmune thyroiditis: Prevention of disease and decrease of EAT-specific T cells
46. Disparate roles for TNF-α and Fas ligand in concanavalin A-induced hepatitis
47. Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor
48. Cloning and expression of murine interferon cDNA
49. T cell activation-associated hepatic injury: Mediation by tumor necrosis factor and protection by interleukin 6
50. Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis
51. Interleukin-13 prevents autoimmune diabetes in NOD mice
52. Fusidic acid suppresses nitric oxide toxicity in pancreatic islet cells
53. IFN-γ action on pancreatic beta cells causes class I MHC upregulation but not diabetes
54. Effect of fusidic acid on interleukin-1 (IL-1)- and IL-6-induced pancreatic β-cell function in rats
55. Immune intervention in type 1 diabetes mellitus
56. Insulin-dependent diabetes mellitus as an autoimmune disease
57. Cyclosporin prevents diabetes in BB Wistar rats
58. Prevention of diabetes mellitus in the BB/W rat with cyclosporin A
59. Preventive effects of cyclosporin on diabetes in NOD mice
60. Effect of cyclosporin A on low-dose streptozotocin diabetes in mice